Current and future directions in the treatment of squamous cell carcinoma of the head and neck: multidisciplinary symposium on head and neck cancer

Author： Haddad Robert

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.10, Iss.2, 2006-04, pp. : 333-336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multidisciplinary Symposium on Head and Neck Cancer

By Agulnik Mark Siu Lillian L

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 489-494

Informa Healthcare

Access to resources Recommend Favorite

Afatinib in the treatment of head and neck squamous cell carcinoma

By Ferrarotto Renata Gold Kathryn A

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 135-143

Informa Healthcare

Access to resources Recommend Favorite

EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma

By Sundvall Maria Karrila Anna Nordberg Janne Grénman Reidar Elenius Klaus

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 185-201

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy for squamous-cell carcinoma of the head and neck

By Papaspyrou Giorgos Werner Jochen A Dietz Andreas

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 397-409

Informa Healthcare

Access to resources Recommend Favorite

Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma

Current Molecular Pharmacology, Vol. 9, Iss. 3, 2016-08 ,pp. : 226-230

Bentham Science Publishers

Access to resources Recommend Favorite